Maxillary osteosarcoma associated with a dental implant: Report of a case and review of the literature regarding implant-related sarcomas

Journal of the American Dental Association

Volumn 139, Issue 8, 2008, Pages 1052-1059

  McGuff, H Stan ^a   Heim Hall, Josefine ^a   Holsinger, F Christopher ^b   Jones, Archie A ^c   O'Dell, Daniel S ^d   Hafemeister, Adam C ^e  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d University of Texas Medical School ^*

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Biomaterials; Cancer; Dental implants; Osteosarcoma; Titanium

Indexed keywords

EID: 52449091529     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0307     Document Type: Article

References (63)

1. Esquivel-Upshaw J. Dental implants. In: Anusavice KJ, ed. Phillips' Science of Dental Materials. 11th ed. St. Louis: Saunders; 2003:759-780.
2. Ratner BD, Hoffman AS, Scheon FJ, Lemons JE. Biomaterials science: a multidisciplinary endeavor. In: Ratner BD, ed. Biomaterials Science: An Introduction to Materials in Medicine. 2nd ed. Amsterdam, Netherlands: Elsevier Academic Press; 2004:3.
3. Lekholm U, Grondahl K, Jemt T. Outcome of oral implant treatment in partially edentulous jaws followed 20 years in clinical function. Clin Implant Dent Relat Res 2006;8(4):178-186.
4. Romeo E, Chiapasco M, Ghisolfi M, Vogel G. Long-term clinical effectiveness of oral implants in the treatment of partial edentulism: seven-year life table analysis of a prospective study with ITI dental implants system used for single-tooth restorations. Clin Oral Implants Res 2002;13(2):133-143.
5. Lekholm U, Gunne J, Henry P, et al. Survival of the Brånemark implant in partially edentulous jaws: a 10-year prospective multicenter study. Int J Oral Maxillofac Implants 1999;14(5):639-645.
6. Keel SB, Jaffe KA, Petur Nielsen G, Rosenberg AE. Orthopaedic implant-related sarcoma: a study of twelve cases. Mod Pathol 2001;14(10):969-977.
7. Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis: analytic review of 46 cases. J Arthroplasty 2006;2(3):311-323.
8. Scheon FJ. Tumorigenesis and biomaterials. In: Ratner BD, ed. Biomaterials Science: An Introduction to Materials in Medicine. 2nd ed. Amsterdam, Netherlands: Elsevier Academic Press; 2004:339-344.
9. Kirkpatrick CJ, Alves A, Kohler H, et al. Biomaterial-induced sarcoma: a novel model to study preneoplastic change. Am J Pathol 2000; 156(4):1455-1467.
10. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Cancer incidence in Finnish hip replacement patients from 1980 to 1995: a nationwide cohort study involving 31,651 patients. J Arthroplasty 1999;14(3):272-280.
11. Case CP, Langkamer VG, Howell RT, et al. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop Relat Res 1996;(329 suppl):S269-S279.
12. Jaffe KA, Morris SG, Lemons JE, Robinson LH. Sarcomas around implants: three cases and a review of the literature. J South Orthop Assoc 1994;3:127-134.
13. Jacobs JJ, Rosenbaum DH, Hay RM, Gitelis S, Black J. Early sarcomatous degeneration near a cementless hip replacement. J Bone Joint Surg Br 1992;74(5):740-744.
14. Jacobs JJ, Skipor AK, Black J, Urban R, Galante JO. Release and excretion of metal in patients who have a total hip-replacement component made of titanium-base alloy. J Bone Joint Surg Am 1991;73(10):1475-1486.
15. Khurana JS, Rosenberg AE, Kattapuram SV, Fernandez OS, Ehara S. Malignancy supervening on an intramedullary nail. Clin Orthop Relat Res 1991;(267):251-254.
16. Ward JJ, Thornbury DD, Lemons JE, Dunham WK. Metal-induced sarcoma: a case report and review of the literature. Clin Orthop Relat Res 1990;(252):299-306.
17. Hughes AW, Sherlock DA, Hamblen DL, Reid R. Sarcoma at the site of a single hip screw: a case report. J Bone Joint Surg Br 1987;69(3):470-472.
18. Memoli VA, Urban RM, Alroy J, Galante JO. Malignant neoplasms associated with orthopedic implant materials in rats. J Orthop Res 1986;4(3):346-355.
19. Pedley RB, Meachim G, Williams DF. Tumor induction by implant materials. In: Williams DF, ed. Fundamental Aspects of Biocompatibility. Vol. 2. Boca Raton, Fla.: CRC Press; 1981:175-202.
20. Sinibaldi K, Rosen H, Liu SK, DeAngelis M. Tumors associated with metallic implants in animals. Clin Orthop Relat Res 1976;(118):257-266.
21. Sunderman FW Jr. Metal carcinogenesis in experimental animals. Food Cosmet Toxicol 1971;9(1):105-120.
22. Cole BJ, Schultz E, Smilari TF, Hajdu SI, Krauss ES. Malignant fibrous histiocytoma at the site of a total hip replacement: review of the literature and case report. Skeletal Radiol 1997;26(9):559-563.
23. Brien WW, Salvati EA, Healey JH, Bansal M, Ghelman B, Betts F. Osteogenic sarcoma arising in the area of a total hip replacement: a case report. J Bone Joint Surg Am 1990;72(7):1097-1099.
24. Harris WR. Chondrosarcoma complicating total hip arthroplasty in Maffucci's syndrome. Clin Orthop Relat Res 1990;(260):212-214.
25. Lamovec J, Zidar A, Cucek-Plenicar M. Synovial sarcoma associated with total hip replacement: a case report. J Bone Joint Surg Am 1988;70(10):1558- 1560.
26. van der List JJ, van Horn JR, Sloof TJ, ten Cate LN. Malignant epithelioid hemangioendothelioma at the site of a hip prosthesis. Acta Orthop Scand 1988;59(3):328-330.
27. Weber PC. Epithelioid sarcoma in association with total knee replacement: a case report. J Bone Joint Surg 1986;68(5):824-826.
28. Dodion P, Putz P, Amiri-Lamraski MH, Efira A, Martelaere E, Heimann R. Immunoblastic lymphoma at the site of an infected vitalhum bone plate. Histopathology 1982;6(6):807-813.
29. McDonald I. Malignant lymphoma associated with internal fixation of a fractured tibia. Cancer 1981;48(4):1009-1011.
30. Tayton KJ. Ewing's sarcoma at the site of a metal plate. Cancer 1980;45(2):413-415.
31. Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 2006;125(4):555-581.
32. Unni KK. Osteosarcoma of bone. J Orthop Sci 1998;3(5):287-294.
33. Smith RB, Apostolakis LW, Karnell LH, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003;98(8):1670-1680.
34. Neville BW. Oral and Maxillofacial Pathology. 2nd ed. Philadelphia: W.B. Saunders; 2002:574-577.
35. Regezi JA, Sciubba JJ. Oral Pathology: Clinical Pathologic Correlations. 4th ed. St. Louis: Saunders; 2003:321-326.
36. Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 2007;65(7):1286-1291.
37. Karnell LH, Hoffman HT, Smith RB, Robinson RA. Osteosarcoma of the Head and Neck: UIHC Experience Compared to National Data. UIHC Annual Report 1; 2003. "www.uihealthcare.com/depts/cancercenter/patients/2003osteosarcoma. pdf". Accessed June 26, 2008.
38. Pellitteri PK, Ferlito A, Bradley PJ, Shaha AR, Rinaldo A. Management of sarcomas of the head and neck in adults. Oral Oncol 2003;39(1):2-12.
39. Mardinger O, Givol N, Talmi YP, Taicher S. Osteosarcoma of the jaw: the Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91(4):445-451.
40. Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90(3):323-332.
41. Lysaght MJ, O'Loughlin JA. Demographic scope and economic magnitude of contemporary organ replacement therapies. ASAIO J 2000;46(5):515-521.
42. Mushinski M. Average charges for hip replacement surgeries: United States, 1997. Stat Bull Metrop Insur Co 1999;80(1):32-40.
43. Abu El-Naaj I, Trost O, Tagger-Green N, et al. Peri-implantitis or squamous cell carcinoma? [in French]. Rev Stomatol Chir Maxillofac 2007;108(5):458-460.
44. Czerninski R, Kaplan I, Almoznino G, Maly A, Regev E. Oral squamous cell carcinoma around dental implants. Quintessence Int 2006;37(9):707-711.
45. Shaw R, Sutton D, Brown J, Cawood J. Further malignancy in field change adjacent to osseointegrated implants. Int J Oral Maxillofac Surg 2004;33(4):353-355.
46. Block MS, Scheufler E. Squamous cell carcinoma appearing as peri-implant bone loss: a case report. J Oral Maxillofac Surg 2001;59(11):1349-1352.
47. Moxley JE, Stoelinga PJ, Blijdorp PA. Squamous cell carcinoma associated with a mandibular staple implant. J Oral Maxillofac Surg 1997;55(9):1020-1022.
48. Clapp C, Wheeler JC, Martof AB, Levine PA. Oral squamous cell carcinoma in association with dental osseointegrated implants: an unusual occurrence. Arch Otolaryngol Head Neck Surg 1996;122(12):1402-1403.
49. Friedman KE, Vernon SE. Squamous cell carcinoma developing in conjunction with a mandibular staple bone plate. J Oral Maxillofac Surg 1983;41(4):265-266.
50. Saglik Y, Arikan M, Altay M, Yildiz Y. Squamous cell carcinoma arising in chronic osteomyelitis. Int Orthop 2001;25(6):389-391.
51. Poggio CE. Plasmacytoma of the mandible associated with a dental implant failure: a clinical report. Clin Oral Implants Res 2007;18(4):540-543.
52. Dib LL, Soares AL, Sandoval RL, Nannmark U. Breast metastasis around dental implants: a case report. Clin Implant Dent Relat Res 2007;9(2):112-115.
53. Verhoeven JW, Cune MS, van Es RJ. An unusual case of implant failure. Int J Prosthodont 2007;20(1):51-54.
54. McGregor DB, Baan RA, Partensky C, Rice JM, Wilbourn JD. Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies: a report of an IARC Monographs Programme Meeting. International Agency for Research on Cancer. Eur J Cancer 2000;36(3):307-313.
55. Williams DF. Titanium and titanium alloys. In: Williams DF, ed. Fundamental Aspects of Biocompatibility. Vol. 1. Boca Raton, Fla.: CRC Press; 1981:9-44.
56. Williams DF. Toxicology of implanted metals. In: Williams DF, ed. Fundamental Aspects of Biocompatibility. Vol. 2. Boca Raton, Fla.: CRC Press; 1981:57.
57. Noguera Aguilar JF, Zurita Romero M, Tortajada Collado C, Amengual Antich I, Soro Gosalvez JA, Rial Planas R. Perianastomotic colonic tumors after inclusion of titanium or Lactomer in the anastomotic suture line: an experimental study in rats. Rev Esp Enferm Dig 2000;92(1):36-43.
58. Yamadori I, Ohsumi S, Taguchi K. Titanium dioxide deposition and adenocarcinoma of the lung. Acta Pathol Jpn 1986;36(5):783-790.
59. Rahal MD, Delorme D, Branemark PI, Osmond DG. Myelointegration of titanium implants: B lymphopoiesis and hemopoietic cell proliferation in mouse bone marrow exposed to titanium implants. Int J Oral Maxillofac Implants 2000;15(2):175-184.
60. Ogawa T, Nishimura I. Genes differentially expressed in titanium implant healing. J Dent Res 2006;85(6):566-570.
61. Ogawa T, Nishimura I. Different bone integration profiles of turned and acid-etched implants associated with modulated expression of extracellular matrix genes. Int J Oral Maxillofac Implants 2003;18(2):200-210.
62. Ogawa T, Sukotjo C, Nishimura I. Modulated bone matrix-related gene expression is associated with differences in interfacial strength of different implant surface roughness. J Prosthodont 2002;11(4):241-247.
63. Takeuchi K, Saruwatari L, Nakamura HK, Yang JM, Ogawa T. Enhanced intrinsic biomechanical properties of osteoblastic mineralized tissue on roughened titanium surface. J Biomed Mater Res A 2005;72(3):296-305.